HIKMA PHARMS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HIKMA PHARMS, and what generic and branded alternatives to HIKMA PHARMS drugs are available?
HIKMA PHARMS has thirty-six approved drugs.
There are three tentative approvals on HIKMA PHARMS drugs.
Summary for HIKMA PHARMS
| US Patents: | 0 |
| Tradenames: | 32 |
| Ingredients: | 31 |
| NDAs: | 36 |
Drugs and US Patents for HIKMA PHARMS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Pharms | MODAFINIL | modafinil | TABLET;ORAL | 090543-001 | Sep 26, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Hikma Pharms | PARICALCITOL | paricalcitol | SOLUTION;INTRAVENOUS | 205917-002 | Nov 18, 2014 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Hikma Pharms | TOPIRAMATE | topiramate | TABLET;ORAL | 091185-002 | Nov 25, 2013 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
